Guardian Pharmacy Services GRDN
Valuation
Multiples measured against the stock's own five-year history
Around its usual level · 58th percentile, 5-year average 19.7x
#2471 of 2993 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 85th percentile, 5-year average 13.7x
#5000 of 5330 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 100th percentile, 5-year average 1.4x
#2652 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 11.74 | – | 13.67 | 85% (pricier than usual) | #5000 of 5330 (1 = cheapest) |
| PE | 42.32 | 37.19 | 19.75 | 58% (pricier than usual) | #2471 of 2993 (1 = cheapest) |
| PS | 2.15 | 2.06 | 1.36 | 100% (pricier than usual) | #2652 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on GRDN.
Sign in to join the discussion.